Atomo Diagnostics Limited (AT1.AX)
- Previous Close
0.0300 - Open
0.0300 - Bid 0.0300 x 2132800
- Ask 0.0320 x 10104900
- Day's Range
0.0300 - 0.0320 - 52 Week Range
0.0200 - 0.1000 - Volume
279,718 - Avg. Volume
1,496,502 - Market Cap (intraday)
19.176M - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 26, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
atomodiagnostics.comRelated News
Performance Overview: AT1.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AT1.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AT1.AX
Valuation Measures
Market Cap
19.18M
Enterprise Value
12.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.79
Price/Book (mrq)
1.40
Enterprise Value/Revenue
4.13
Enterprise Value/EBITDA
-1.84
Financial Highlights
Profitability and Income Statement
Profit Margin
-237.01%
Return on Assets (ttm)
-24.37%
Return on Equity (ttm)
-44.83%
Revenue (ttm)
3.11M
Net Income Avi to Common (ttm)
-7.37M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
6.51M
Total Debt/Equity (mrq)
1.25%
Levered Free Cash Flow (ttm)
-2.14M
Company Insights: AT1.AX
AT1.AX does not have Company Insights